MAP1LC3A and metabolic dysfunction-associated steatotic liver disease: Meanwhile, the in vivo results demonstrated that circLDLR significantly up-regulated LC3 and inhibited p62, and 3-MA could reverse the impacts of circLDLR overexpression, indicating that circLDLR overexpression could improve the NAFLD development via the autophagy signaling pathway activation.